December 22, 2016 / 3:05 AM / 7 months ago

BRIEF-Sun Pharma to buy Novartis' cancer drug Odomzo

1 Min Read

Dec 22 (Reuters) - Sun Pharmaceutical Industries Ltd

* Says Sun Pharma to acquire branded oncology product Odomzo for global markets

* Says acquisition of Odomzo from Novartis

* Says greement has been signed for an upfront payment of US$ 175 million and additional milestone payments.

* says Odomzo is used for treatment of adult patients with labcc that has recurred following surgery or radiation therapy Source text: bit.ly/2i2LK7M Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below